Texas Attorney General Ken Paxton filed a lawsuit against Johnson & Johnson and Kenvue, the makers of Tylenol, alleging that they deliberately concealed the drug’s purported connections to autism and ADHD. The legal action follows recent statements by U.S. President Donald Trump, who without scientific backing claimed that using Tylenol during pregnancy could lead to autism in children.
Having marketed Tylenol for over sixty years, Johnson & Johnson later established Kenvue in 2023, which now distributes the brand. Kenvue has vigorously defended the safety of Tylenol, asserting that acetaminophen is the safest pain relief option for pregnant women throughout their pregnancy.
In response to Paxton’s lawsuit, Kenvue emphasized its commitment to safeguarding the accurate information regarding the safety of acetaminophen. Johnson & Johnson refrained from commenting on the legal action, reiterating that Kenvue is accountable for all aspects related to the sale of over-the-counter products, including Tylenol.
Following Paxton’s claims, shares of Kenvue and Johnson & Johnson experienced declines in morning trading. Paxton filed the lawsuit in a Texas state court, alleging that federal authorities have confirmed the risks associated with Tylenol, including the possible development of autism and ADHD when used during pregnancy. He accused Johnson & Johnson and Kenvue of violating Texas laws related to deceptive trade practices and fraudulent transfers.
Trump’s previous announcements regarding the risks of acetaminophen, including the potential link to autism, have sparked controversy. Health Canada has opposed Trump’s assertions, emphasizing that there is no definitive evidence linking acetaminophen use during pregnancy to neurodevelopmental disorders. The Society of Obstetricians and Gynaecologists of Canada has also reiterated the safety of acetaminophen for pregnant women when used as directed.
Numerous private lawsuits have been filed by families claiming that their children developed autism or ADHD due to Tylenol use during pregnancy. While some cases were dismissed, the families are set to appeal the decision in November. Johnson & Johnson is facing additional legal challenges from over 73,000 plaintiffs who allege they developed cancer after using the company’s talc products.
